#LivingInnovation

Welcome to Pfizer EU Policy

We partner with EU policy-makers and other stakeholders, driven by our purpose: Breakthroughs that change patients’ lives.

Learn more about our team and vision to contribute to more pro-patient and pro-innovation policies in the EU. And don’t hesitate to follow @PfizerEUPolicy on Twitter!

Learn More

scroll-down

Ana Luzuriaga: Targeting Rare Diseases

Pfizer Spain Communication Manager fights for better understanding, treatments, and policy support for rare diseases

Learn more

Tobias Schulz: Health Data

Pfizer Germany Senior Manager, Policy and Public Affairs, built a career on making sure that health data is used in the best ways it can be for patients and society

Learn more

Bharati Shivalkar: Women at Heart

Pfizer’s BeLux Country Medical Director is passionate about fighting cardiovascular disease and empowering women

Learn more

Isabella Grueso: Beating Cancer

Pfizer’s Global Breast Cancer & Precision Medicine Policy Director grew up seeing the importance of Access to Medicines, and applies these lessons to breast cancer policy today

Learn more

Jo Atkinson: Fighting Resistant Infections

Pfizer’s Anti-Infectives Product Lead highlights the importance of R&D with a focus on AMR patients.

Learn more

Video

2:20 min

The EU Pharma Strategy: Pfizer's Vision

We are witnessing a once-in-a-generation legislative revision in Europe.

As a partner of the EU institutions, we aim to ensure that the Pharmaceutical Strategy for Europe delivers both for patients and for innovation. We believe these goals can and should be pursued in parallel.

Meet the Team

EU Register of Interest Representatives # 4263301811-33

@PfizerEUPolicy May 31

Ana's daughter was diagnosed with Potocki-Lupski syndrome, a rare disorder that affects children's growth. Today, she works to ensure a better future for #RareDisease patients. 👇 #LivingInnovation #EUPharmaStrategy

@PfizerEUPolicy May 30

We would like to thank all the participants of Pfizer's 5th Annual Global AMR Patient Summit of last week. The patient voice is critical for #AMR to stay on top of the political agenda in the EU and globally. #LivingInnovation https://t.co/AJgok9aHBF

@PfizerEUPolicy May 30

The Medtech Forum begins today! @medtecheurope Looking forward to the discussions about #EHDS and how the use of real-world data can improve research and innovation. https://t.co/Gi5drUGl7P #LivingInnovation https://t.co/q7JzX1XPm2

@PfizerEUPolicy May 26

🤔 Have you kept track of all the ground-breaking advances in medical technology? Or new ones coming in the near future? #AI and data tech offer incredible benefits 👇 https://t.co/CvLTvZy2jm #LivingInnovation #EHDS https://t.co/AVL4DD1AcY

@PfizerEUPolicy May 25

RT @Vision4Health: Health systems must be better connected: to avoid fragmentation, we need to define common specifications for infrastructure and standardised requirements for #data processing at an early stage. Read ... https://twitter.com/PfizerEUPolicy/status/1661721908671311872

@PfizerEUPolicy May 25

Today, 🇪🇺 Cancer Week begins. #EWAC "Cancer patients facing delays of more than two years for new medicines in countries like Malta and Bulgaria do not have the luxury of waiting around for lengthy and unpredictable legislative developments." - @NathalieMoll #LivingInnovation https://t.co/EX0xMoVFlr

@PfizerEUPolicy May 23

We are excited to host Pfizer's 5th Annual Global AMR Patient Summit tomorrow in Brussels. Tackling #AMR is crucial to public health and only by partnering with patient advocacy groups we can make the difference. #LivingInnovation https://t.co/eiUvM4gjIU

@PfizerEUPolicy May 22

Diagnosing rare diseases is complex and often takes time. #PfizerColleague Ana Luzuriaga, whose daughter suffers from a #RareDisease, had to wait more than 2 years to get a diagnosis. This is her #LivingInnovation story ⬇️ https://t.co/TyyBBShiQl https://t.co/uIyDPJj4vV

@PfizerEUPolicy May 19

Tomorrow is #ClinicalTrialsDay. A celebration of the 1st clinical trial that took place more than 250 years ago. They are the backbone of medicine development: scientists, researchers, clinicians and patients behind these studies truly make our world healthier. #LivingInnovation https://t.co/2jH1U7BuCH

@PfizerEUPolicy May 18

Today is #WorldAidsVaccineDay. While progress has been made, the disease cannot be eradicated without an effective vaccine. For this, a strong EU R&D ecosystem is key. Weakening incentives will negatively impact investment & innovation. #LivingInnovation #EUPharmaStrategy